Carlos Solórzano
InvestorPrincipal at S32
San Francisco Bay Area
Writes $10K – $50K checks · typically $25K
Experience
- Ally Bridge GroupPrincipalcurrent2024 — present
- Ally Bridge GroupInvestor in residence2024San Francisco Bay Area
- Section 32Sr. Principal2022 — 2024San Francisco Bay Area
- Pivotal Life SciencesSr. Associate2019 — 2022San Francisco Bay Area
- Ultragenyx Pharmaceutical Inc.Assoc Director, Corporate Strategy2018 — 2019
- Deutsche BankEquity Research Associate - Biotechnology2016 — 2018San Francisco, CA
- Oppenheimer & Co. Inc.Equity Research Associate - Biotechnology2015 — 2016San Francisco, CA
- University of California, San FranciscoNIH Postdoctoral Fellow2010 — 2015San Francisco Bay Area
- Oxbridge Biotech RoundtablePresident - Bay Area Chapter2014San Francisco Bay Area
Education
- UC IrvinePh.D., Pharmacology and Toxicology2005 — 2010
- Keck Graduate InstituteIntensive Summer Business Course2014
- California State Polytechnic University-PomonaB.Sc., Chemical Engineering2000 — 2005
Skills & more
Molecular BiologyPharmacologyBiochemistryCell BiologyNeuroscienceCell CultureAnimal ModelsDrug DiscoveryToxicologyConfocal MicroscopyLaboratoryIn Vivo
+7 more
ImmunohistochemistryEnzyme KineticsInflammationFluorescence MicroscopyIn VitroPainAnalytical ChemistryLanguages French · Spanish
- Series 7, 63, 86, 87
From Carlos's professional profile.
Colleagues at S32
Network5
Ainhoa Maiz
Principal at S32
Andy Harrison
General Partner, CEO at S32
Ayesha Arora
Venture Partner at S32
Bill Maris
General Partner, Founder at S32
Mike Pellini
General Partner at S32
Investors connected to Carlos in public investor directories — a warm-intro map.
Frequently asked questions
- Where does Carlos Solórzano work?
- Carlos Solórzano is Principal at S32.
- What check size does Carlos Solórzano write?
- Carlos Solórzano typically writes checks of $10K – $50K.
Same school
Also attended UC Irvine117
Christian BuergerPortfolio Development at Intel CapitalJonathan GiegCommunity Manager at Pantera CapitalRyan LaurinManaging Director at Marlin Equity PartnersPascal KroteePrincipal, Ph.D. at RiverVest Venture PartnersZack IsaacsonVenture Partner at Rackhouse Venture Management LpCameron BaharVenture Partner at Think+ Ventures Management, Llc
+ 111 more
Also attended Keck Graduate Institute7
Seth LieblichInvestment Team at 8VCMira ChaurushiyaManaging Director at Westlake Village BioPartnersMary GuanInvestor at Sand Hill AngelsKavya TallapakaConsulting at Rock HealthAdar Makovski SilversteinPrincipal at Arkin CapitalCurt HerbertsInvestor at Premji Invest
+ 1 more
Also attended California State Polytechnic University-Pomona12
Neha KumarVenture Partner at Floating PointKevin CovertCo-Founder & Managing Director at BTECH CONSORTIUMAri HorieImpact Partner at Fresco CapitalNicole KinseyVP Content, Partner at StartUp HealthAnil ParyaniInvestor at G2 Venture PartnersOmar BenitezVP, Investments at Acumen America
+ 6 more
Shared employers
Also worked at Section 3212
Andy HarrisonGeneral Partner, CEO at S32Mike PelliniGeneral Partner at S32Wesley TilluPartner at S32 focused on frontier technology investmentsAyesha AroraVenture Partner at S32Jennifer KercherGeneral Counsel at Westlake Village BioPartnersSteve KafkaGeneral Partner at S32
+ 6 more
Also worked at Pivotal Life Sciences10
Glenn BatchelderVenture Partner at Pivotal Life SciencesPeter BisgaardManaging Director at Pivotal Life SciencesRob HopfnerManaging Director at Pivotal Life SciencesJeni LeePartner at Pivotal Life SciencesBenjamin LiVice President at Pivotal Life SciencesBrian MillsVice President at Pivotal Life Sciences
+ 4 more
Also worked at Ultragenyx Pharmaceutical Inc.5
Also worked at Deutsche Bank509
Bill GurleyGeneral Partner Emeritus at Benchmark; author of Above the Crowd; BG2 co-hostFunmi GarrickFinance and Operations at Impact America FundGiuseppe IademarcoHead of Global Partnership at P101 VenturesJeppe ZinkPartner at NorthzoneDan MoreheadFounder & CEO at Pantera CapitalJavier BorreroSenior Director at Inveready Technology Investment Group
+ 503 more